CHRND anticorps (AA 22-245)

N° du produit ABIN5611361

Détail du produit anti-CHRND anticorps

Antigène: CHRND (Cholinergic Receptor, Nicotinic, delta (Muscle) (CHRND))

Épitope: AA 22-245

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CHRND est non-conjugé

Application: Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Fonction: CHRND Antibody

Purification: Purified antibody

Immunogène: Purified recombinant fragment of human CHRND (AA: 22-245) expressed in E. Coli.

Clone: 1H1F9

Isotype: IgG1

Information d'application

Indications d'application:

ELISA: 1/10000

FCM: 1/200 - 1/400

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified antibody in PBS with 0.05 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Détails sur CHRND

Antigène: CHRND (Cholinergic Receptor, Nicotinic, delta (Muscle) (CHRND))

Autre désignation: CHRND (CHRND Produits)

Synonymes: anticorps ACHRD, anticorps CMS2A, anticorps FCCMS, anticorps SCCMS, anticorps wu:fa01e01, anticorps zgc:110469, anticorps CHNRD, anticorps MGC97613, anticorps Achr-4, anticorps Acrd, anticorps L10076, anticorps chnrd, anticorps chrng, anticorps cholinergic receptor nicotinic delta subunit, anticorps cholinergic receptor, nicotinic, delta (muscle), anticorps cholinergic receptor, nicotinic, delta, anticorps cholinergic receptor nicotinic gamma subunit, anticorps cholinergic receptor, nicotinic delta, anticorps cholinergic receptor, nicotinic, delta polypeptide, anticorps cholinergic receptor, nicotinic delta L homeolog, anticorps CHRND, anticorps chrnd, anticorps CHRNG, anticorps Chrnd, anticorps chrnd.L

Sujet:

Description: The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene.

Aliases: ACHRD, CMS2A, CMS3A, CMS3B, CMS3C, FCCMS, SCCMS

Poids moléculaire: 58.8kDa

ID gène: 1144

HGNC: 1144

UniProt: Q07001